How does A199730's PB Ratio compare to its peers?

Insufficient data to calculate A199730's Price-To-Book Ratio vs. peers for valuation analysis.

How does A199730's PB Ratio compare vs other companies in the KR Life Sciences Industry?

Insufficient data to calculate A199730's Price-To-Book Ratio vs. industry for valuation analysis.

What is A199730's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate A199730's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of A199730 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate A199730's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

A199730 Stock Overview

Bioinfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials. More details

A199730 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	2/6

Risk Analysis

Has not reported any financial data

Does not have a meaningful market cap (₩32B)

Volatile share price over the past 3 months compared to the KR market

My Notes

Capture your thoughts, links and company narrative

BioInfra Co., Ltd. Competitors

Green Lifescience

KOSDAQ:A114450

₩34.3b

Celemics

KOSDAQ:A331920

₩26.5b

WOOJUNG BIO

KOSDAQ:A215380

₩26.2b

Genolution

KOSDAQ:A225220

₩41.8b

Price History & Performance

Summary of share price highs, lows and changes for BioInfra
Historical stock prices
Current Share Price	₩6,760.00
52 Week High	₩12,930.00
52 Week Low	₩5,660.00
Beta	0
1 Month Change	2.42%
3 Month Change	-33.07%
1 Year Change	-40.18%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-77.01%

Recent updates

Shareholder Returns

	A199730	KR Life Sciences	KR Market
7D	-1.2%	-5.6%	-3.7%
1Y	-40.2%	32.2%	-10.4%

Return vs Industry: A199730 underperformed the KR Life Sciences industry which returned 32.2% over the past year.

Return vs Market: A199730 underperformed the KR Market which returned -10.4% over the past year.

Price Volatility

Is A199730's price volatile compared to industry and market?
A199730 volatility
A199730 Average Weekly Movement	10.7%
Life Sciences Industry Average Movement	8.9%
Market Average Movement	6.6%
10% most volatile stocks in KR Market	12.7%
10% least volatile stocks in KR Market	3.3%

Stable Share Price: A199730's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: A199730's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

Founded	Employees	CEO	Website
2007	n/a	n/a	www.bioinfrakorea.co.kr

Bioinfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials. Its primary product is a bioequivalence test for generic drugs, a phase 1 test for incrementally modified drugs; and a phase 1 sample analysis for other new substances. The company was founded in 2007 and is based in Yongin-si, South Korea.

BioInfra Co., Ltd. Fundamentals Summary

How do BioInfra's earnings and revenue compare to its market cap?
A199730 fundamental statistics
Market cap	₩32.43b
Earnings (TTM)	₩0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is A199730 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A199730 income statement (TTM)
Revenue	₩0
Cost of Revenue	₩0
Gross Profit	₩0
Other Expenses	₩0
Earnings	₩0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did A199730 perform over the long term?

See historical performance and comparison

Dividends

8.9%

Current Dividend Yield

n/a

Payout Ratio

Does A199730 pay a reliable dividends?

See A199730 dividend history and benchmarks

When do you need to buy A199730 by to receive an upcoming dividend?
BioInfra dividend dates
Ex Dividend Date	Dec 27 2024
Dividend Pay Date	Apr 15 2025
Days until Ex dividend	4 days
Days until Dividend pay date	113 days

Does A199730 pay a reliable dividends?

See A199730 dividend history and benchmarks

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/21 09:20
End of Day Share Price	2024/12/20 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BioInfra Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution

BioInfra KOSDAQ:A199730 Stock Report